Please ensure Javascript is enabled for purposes of website accessibility
Cory Renauer

Cory Renauer

tmfang4apples

Cory is a long-term minded analyst focused on the Healthcare Sector. He genuinely enjoys cutting through the complexity to help everyday investors make better decisions.

Recent articles

3-frowning-people-looking-at-a-laptop

3 Top Healthcare Stocks You Can Buy for $100 or Less

It doesn't take a lot of upfront cash to add one of these stocks to your portfolio.


businessman-using-laptop-for-analyzing-data-stock-market

Why Regenxbio Stock Is Way Up Today

American biopharmaceutical giant AbbVie wants access to Regenexbio's gene therapy for macular degeneration.


three-invetors-looking-at-stocks

Here's Why iRhythm Technologies Stock Is Making Big Gains Today

A new CEO with an impressive record is giving investors hope for a rapid turnaround for the heart monitor maker.


doctors-looking-at-tablet

3 Stocks That Could Soar 50% or Better, According to Wall Street

All three of these growth stocks are poised to put up big gains once more investors land on the same page as investment bank analysts who follow them.


laboratory-happiness-getty

Here's Why Iveric Bio Stock Is Rocketing Higher Today

Mixed results from Apellis Pharmaceuticals are good news for Iveric Bio's geographic atrophy program.

frustated-investor-sinking-stock-chart-getty

Here's Why Apellis Pharmaceuticals Is Getting Hammered Today

Conflicting clinical trial results for the company's lead candidate are to blame.


gettyimages-man-in-coffee-shop-with-laptop

Here's Why Ziopharm Oncology Stock Is Up 18% This Week

Recent insider stock purchases were more than a little encouraging.


excited-invetor-trading-stocks

Here's Why ProQR Stock Surged on Thursday

A new collaboration deal with Eli Lilly could be worth up to $1.3 billion.


stock-trader-losing-money-investment-growth-value-getty (1)

Here's Why Humanigen Is Getting Hammered Today

An attempt to earn authorization for lenzilumab hit a wall at the FDA.


smart-doctor-contemplating-your-question-getty

Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought

All of these stocks are more than 40% below their peaks, but at least one important investor thinks they can recover.

three-scientists-laboratory-getty

3 High-Growth Healthcare Stocks to Buy in September

All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector.


happy-young-woman-stock-chart-getty

Why ICU Medical Stock Is Jumping Today

A leading manufacturer of intravenous therapy solutions is about to get a lot bigger.


Cheering-crowd-of-healthcare-providers-getty

Why Pliant Therapeutics Stock Is Surging Today

A positive phase 2 clinical trial readout was a positive step in the right direction for this biotech start-up.


scientist-looking-at-well-plate

3 Biotech Stocks Wall Street Expects to Double Soon

All three stocks on this list can more than double your money according to investment bank analysts who cover them.


investor-with-lots-of-screens-getty

3 Biotech Stocks That Soared to New Heights Last Week

Find out what these industry favorites are doing to impress investors.

investor-watching-stock-chart-rising-getty

Why Impel NeuroPharma Stock Is Soaring Today

The company's nasal spray got a green light from the FDA to treat migraine headaches.


investor-looking-at-stocks-on-tablet

3 Healthcare Stocks Cathie Wood Loves Right Now

Here's why the founder and CEO of ARK Invest set her sights on these three healthcare stocks.


Excited-investor-getty

Here's Why Axsome Therapeutics Stock Is Surging Today

The company still doesn't have much to say about the FDA and its experimental new anti-depression drug.


investors-picking-high-growth-stocks

3 Stocks Near Record Highs to Buy Now

Sometimes, the best stocks to buy are already moving steadily in the right direction.


investor-looking-at-stock-charts

Why RedHill Biopharma Stock Jumped on Tuesday

An analyst on Wall Street thinks the company's commercial and development pipeline has been underestimated.